Medicare Enrolled
Dr. James Libby, MD
Urology Physician · Stockbridge, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Libby from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Libby?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Libby
Dr. James Libby is an urology physician in Stockbridge, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Libby performed 65,281 Medicare services across 4,448 unique beneficiaries.
Between the years covered by Open Payments, Dr. Libby received a total of $7,333 from 16 pharmaceutical and/or device companies across 64 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Libby is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 1% volume in GA
$7,333 industry payments
Medicare Practice Summary
Medicare Utilization ↗65,281
Medicare services
Top 1% in GA for urology physician
4,448
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,436 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone injection An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams. |
54,500 | $0 | $0 |
| BCG treatment for bladder cancer | 1,974 | $2 | $5 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,880 | $0 | $2 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,632 | $2 | $15 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
852 | $7 | $70 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
759 | $86 | $315 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
598 | $67 | $165 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
567 | $9 | $213 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
404 | $75 | $519 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
377 | $8 | $15 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
217 | $43 | $271 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
192 | $0 | $8 |
| Injection, triptorelin pamoate, 3.75 mg | 180 | $294 | $900 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
162 | $166 | $800 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
148 | $110 | $380 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
110 | $10 | $100 |
| PSA test (prostate cancer screening) | 95 | $18 | $54 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
85 | $82 | $246 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
63 | $64 | $400 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
62 | $23 | $100 |
| Injection, garamycin, gentamicin, up to 80 mg | 43 | $2 | $5 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
38 | $438 | $2,354 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
33 | $82 | $889 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
31 | $18 | $54 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
31 | $25 | $215 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
27 | $237 | $1,000 |
| Ultrasound of scrotum An imaging test that uses sound waves to create pictures of the scrotum and its contents. It helps evaluate the testicles and surrounding structures. |
27 | $75 | $293 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
25 | $233 | $764 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
23 | $185 | $1,565 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
20 | $163 | $583 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
20 | $100 | $343 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
20 | $25 | $75 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
18 | $312 | $1,346 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
15 | $29 | $503 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
15 | $87 | $1,477 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
15 | $8 | $25 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
12 | $131 | $1,120 |
| Endoscopic repair of ureteral stricture A procedure to widen or fix a narrowed section of the ureter using an endoscope inserted into the body. |
11 | $206 | $1,084 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
89.7% medium
10.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,333
Total received (2018-2024)
Avg $1,048/year across 7 years
Top 30% in GA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
16
Companies
64
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$5,485 (74.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,848 (25.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$232
2023
$140
2022
$240
2021
$356
2020
$100
2019
$6,018
2018
$247
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
KOELIS Inc.
$154
Sumitomo Pharma America, Inc.
$78
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Metuchen Pharmaceuticals
$5,292
Coloplast Corp
$409
Astellas Pharma US Inc
$388
Myovant Sciences Inc.
$238
Avadel Specialty Pharmaceuticals, LLC
$206
KOELIS Inc.
$154
Sumitomo Pharma America, Inc.
$152
BOSTON SCIENTIFIC CORPORATION
$130
Medical Device Business Services, Inc.
$124
Boston Scientific Corporation
$92
Blue Earth Diagnostics Limited
$64
ConvaTec Inc.
$43
AbbVie, Inc.
$18
Acerus Pharmaceuticals Corporation
$14
Travere Therapeutics, Inc.
$6
Retrophin, Inc.
$4
Top 3 companies account for 83.0% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AMS 700 CXR RTE Kit · Axumin · CERTUS 140 MICROWAVE ABLATION SYSTEM · GENERAL ERECTILE DYSFUNCTION · GENTLECATH · General - Erectile Dysfunction · Lupron Depot · MYRBETRIQ · Natesto · Noctiva · ORGOVYX · Rezum Generator · SPACEOAR VUE · SPEEDICATH · Stendra · TITAN · Thiola · Trinity · XTANDI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (75%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Urology physicians within 10 mi
105
Per 100K population
42.8
County median income
$81,612
Nearest hospital
PIEDMONT HENRY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Libby is a mixed practice specialist, with above-average Medicare volume (top 1% in GA), with speaking/promotional industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Libby experienced with testosterone injection?
Based on Medicare claims data, Dr. Libby performed 54,500 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Libby receive payments from pharmaceutical companies?
Yes. Dr. Libby received a total of $7,333 from 16 companies across 64 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Libby's costs compare to other urology physicians in Stockbridge?
Dr. Libby's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Libby) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Stockbridge
Browse urology physicians in Stockbridge ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in GA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in GA
Which GA urology physicians receive the most from drug and device companies.
By company
Metuchen Pharmaceuticals Payments to Doctors
See all physicians who received payments from Metuchen Pharmaceuticals.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology